<DOC>
	<DOCNO>NCT02459977</DOCNO>
	<brief_summary>Basiliximab routine induction therapeutic agent even well-matched live kidney transplantation ( KT ) tacrolimus-based immunosuppression Korea . As tacrolimus different drug cyclosporine , investigator study usefulness tacrolimus-based immunosuppression without basiliximab well match live KT .</brief_summary>
	<brief_title>The Usefulness Tacrolimus Without Basiliximab Well Matched Living Renal Transplantation Korea</brief_title>
	<detailed_description>The investigator omit basiliximab induction therapy patient underwent one three-HLA mismatch live donor renal transplantation . Participants receive ABO compatible T-flow negative transplant . The investigator compare result intervention group conventionally treat control group ( age sex match patient underwent one three-HLA mismatch live donor renal transplant basiliximab induction therapy ) .</detailed_description>
	<mesh_term>Basiliximab</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>ABO compatible Tflow negative transplant Living kidney transplantation Tacrolimus base immunosuppression Multiorgan transplantation Zeromismatch transplantation ( use cyclosporine instead FK506 )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>